Definition
Mofebutazone is a chemical compound that has been reported in some pharmaceutical literature as belonging to the class of non‑steroidal anti‑inflammatory drugs (NSAIDs), specifically as a pyrazolone derivative.
Overview
The drug is occasionally mentioned in older pharmacological catalogs and some regional formularies as an analgesic and anti‑inflammatory agent. It is described as having therapeutic applications similar to other pyrazolone NSAIDs, such as relief of mild to moderate pain and reduction of inflammation. The extent of its clinical usage, regulatory status, and prevalence in contemporary medicine appear limited; many modern references to the compound are sparse, and it does not feature prominently in major drug compendia.
Etymology / Origin
The name “mofebutazone” likely combines a prefix “mo‑” (potentially indicating a specific chemical modification) with the suffix “‑butazone,” a term historically used for pyrazolone derivatives (e.g., phenylbutazone). This construction suggests that the compound was derived or marketed as a variant of the butazone family of drugs.
Characteristics
- Chemical class: Pyrazolone‑type NSAID (reported).
- Pharmacodynamics: As with other pyrazolones, mofebutazone is presumed to exert its effect primarily through inhibition of cyclooxygenase (COX) enzymes, leading to decreased prostaglandin synthesis. Specific affinity for COX‑1 versus COX‑2, potency, and metabolic pathways have not been definitively documented in widely accessible scientific sources.
- Therapeutic profile: Reports characterize it as an analgesic and anti‑inflammatory medication, but detailed dosage regimens, efficacy data, and safety profiles are not well‑established in the current literature.
- Regulatory status: Accurate information on its approval status, market availability, or inclusion in pharmacopeias is not confirmed. It does not appear on the lists of currently approved NSAIDs in major regulatory agencies (e.g., FDA, EMA).
Related Topics
- Non‑steroidal anti‑inflammatory drugs (NSAIDs) – a broad category of medications that reduce inflammation and pain by inhibiting cyclooxygenase enzymes.
- Pyrazolones – a subclass of NSAIDs that includes compounds such as phenylbutazone and dipyrone (metamizole).
- Phenylbutazone – a well‑known pyrazolone NSAID, historically used for similar indications.
- Analgesic agents – drugs employed to relieve pain.
- Anti‑inflammatory agents – substances that mitigate inflammatory processes.
Accurate information is not confirmed.